Est. 1999
Over 25 Years of Experience
Strategic Consulting and Executive Advisory for Healthcare, Pharma, and Biotech.
Since 1999, Waldron and Associates has guided leaders through complex decisions, market transitions, and high-stakes growth.
More than two decades advising global health ecosystems.
Deep operational and strategic expertise across Canada, the USA, Europe, and the Middle East.
Advisors with hands-on experience in commercial strategy, patient access, specialty pharmacy, distribution, and emerging health technologies.
Strategic consulting focused on growth architecture, program design, market expansion, and risk governance.
Executive advisory for senior leaders requiring clear thinking, structured decision support, and high-impact guidance.
Support for scale-ups and established companies transforming operations, strengthening partnerships, and building future-ready models.
Process and financial process audits that test the strength of your operating model, uncover control gaps, and align internal practices with strategic objectives. Through a patented reconciliation platform, we provide end-to-end visibility across complex financial and operational flows, reducing leakage and strengthening compliance.
What we do
Who we support
Healthcare organisations, pharmaceutical manufacturers, biotech innovators, and global partners seeking clarity, structure, and strategic advantage.
Why leaders choose Waldron and Associates:
Independent guidance anchored in real-world execution.
Global insight with regional precision.
A track record of helping companies navigate change, accelerate performance, and position for long-term value.
Principals
Nicole Serena - CEO
Andrew Waldron - President
Work with an advisory team that has been shaping healthcare strategy since 1999.
Connect with Waldron and Associates to discuss your strategic priorities.
